Oxford Nanopore Technologies Ltd (ONT) - Total Liabilities
Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has total liabilities worth GBX141.30 Million GBX (≈ $17.19K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Oxford Nanopore Technologies Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Oxford Nanopore Technologies Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Oxford Nanopore Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ONT asset base.
Oxford Nanopore Technologies Ltd Competitors by Total Liabilities
The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Marwynn Holdings, Inc. Common stock
NASDAQ:MWYN
|
USA | $427.97K |
|
Allied Industrial Ltd
TWO:4702
|
Taiwan | NT$218.53 Million |
|
CKH Food & Health Limited
KQ:900120
|
Korea | ₩10.04 Million |
|
Resverlogix Corp.
TO:RVX
|
Canada | CA$102.36 Million |
|
Rossell India Limited
NSE:ROSSELLIND
|
India | Rs1.12 Billion |
|
Magna Terra Minerals Inc
V:MTT
|
Canada | CA$642.70K |
|
Bankers Investment Trust
LSE:BNKR
|
UK | GBX134.76 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Oxford Nanopore Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Oxford Nanopore Technologies Ltd's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oxford Nanopore Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oxford Nanopore Technologies Ltd (2012–2025)
The table below shows the annual total liabilities of Oxford Nanopore Technologies Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX159.20 Million ≈ $19.37K |
+2.24% |
| 2024-12-31 | GBX155.71 Million ≈ $18.95K |
+16.89% |
| 2023-12-31 | GBX133.21 Million ≈ $16.21K |
+2.21% |
| 2022-12-31 | GBX130.33 Million ≈ $15.86K |
-5.48% |
| 2021-12-31 | GBX137.89 Million ≈ $16.78K |
+44.73% |
| 2020-12-31 | GBX95.28 Million ≈ $11.59K |
+72.58% |
| 2019-12-31 | GBX55.21 Million ≈ $6.72K |
+70.95% |
| 2018-12-31 | GBX32.30 Million ≈ $3.93K |
+25.55% |
| 2017-12-31 | GBX25.72 Million ≈ $3.13K |
+87.69% |
| 2016-12-31 | GBX13.71 Million ≈ $1.67K |
+65.34% |
| 2015-12-31 | GBX8.29 Million ≈ $1.01K |
+93.62% |
| 2014-12-31 | GBX4.28 Million ≈ $520.87 |
+38.19% |
| 2013-12-31 | GBX3.10 Million ≈ $376.94 |
+54.29% |
| 2012-12-31 | GBX2.01 Million ≈ $244.30 |
-- |
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more